Literature DB >> 12381520

Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension.

Yasuko Iwakiri1, Gregory Cadelina, William C Sessa, Roberto J Groszmann.   

Abstract

Systemic vasodilation is the initiating event of the hyperdynamic circulatory state, being most likely triggered by increased levels of vasodilators, primarily nitric oxide (NO). Endothelial NO synthase (eNOS) is responsible for this event. We tested the hypothesis that gene deletion of eNOS and inducible NOS (iNOS) may inhibit the development of the hyperdynamic circulatory state in portal hypertensive animals. To test this hypothesis, we used mice lacking eNOS (eNOS-/-) or eNOS/iNOS (eNOS/iNOS-/-) genes. A partial portal vein ligation (PVL) was used to induce portal hypertension. Sham-operated animals were used as a control. Hemodynamic characteristics were tested 2 wk after surgery. As opposed to our hypothesis, PVL also caused significant reduction in peripheral resistance in eNOS-/- compared with sham animals (0.33 +/- 0.02 vs. 0.41 +/- 0.03 mmHg. min x kg body wt x ml(-1); P = 0.04) and in eNOS/iNOS-/- animals with PVL compared with that of the sham-operated group (0.44 +/- 0.02 vs. 0.54 +/- 0.04; P = 0.03). This demonstrates that, despite gene deletion of eNOS, the knockout mice developed hyperdynamic circulation. Compensatory vasodilator molecule(s) are upregulated in place of NO in the systemic and splanchnic circulation in portal hypertensive animals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381520     DOI: 10.1152/ajpgi.00145.2002

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  15 in total

Review 1.  Animal models of portal hypertension.

Authors:  Juan-G Abraldes; Marcos Pasarín; Juan-Carlos García-Pagán
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

2.  Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosis.

Authors:  Dahai Zhang; Teruo Utsumi; Hui-Chun Huang; Lili Gao; Panjamaporn Sangwung; Chuhan Chung; Kazunori Shibao; Kohji Okamoto; Koji Yamaguchi; Roberto J Groszmann; Levente Jozsef; Zhengrong Hao; William C Sessa; Yasuko Iwakiri
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

3.  Selective stimulation of VEGFR2 accelerates progressive renal disease.

Authors:  Waichi Sato; Katsuyuki Tanabe; Tomoki Kosugi; Kelly Hudkins; Miguel A Lanaspa; Li Zhang; Martha Campbell-Thompson; Qiuhong Li; David A Long; Charles E Alpers; Takahiko Nakagawa
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

4.  Inhibition of VEGF- and NO-dependent angiogenesis does not impair liver regeneration.

Authors:  U Shergill; A Das; D Langer; Rs Adluri; N Maulik; V H Shah
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05       Impact factor: 3.619

Review 5.  The portal hypertension syndrome: etiology, classification, relevance, and animal models.

Authors:  Jaime Bosch; Yasuko Iwakiri
Journal:  Hepatol Int       Date:  2017-10-24       Impact factor: 6.047

6.  Glytan decreases portal pressure via mesentery vasoconstriction in portal hypertensive rats.

Authors:  Qing-Hong Du; Lin Han; Jun-Jie Jiang; Ya Xu; Wei-Hong Li; Peng-Tao Li; Xin-Yue Wang; Xu Jia
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

7.  Hypertensive stretch regulates endothelial exocytosis of Weibel-Palade bodies through VEGF receptor 2 signaling pathways.

Authors:  Yan Xiong; Zhenqian Hu; Xiaofan Han; Beibei Jiang; Rongli Zhang; Xiaoyu Zhang; Yao Lu; Chenyang Geng; Wei Li; Yulong He; Yingqing Huo; Masabumi Shibuya; Jincai Luo
Journal:  Cell Res       Date:  2013-04-23       Impact factor: 25.617

8.  Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation.

Authors:  Anja M Geerts; Eline Vanheule; Marleen Praet; Hans Van Vlierberghe; Martine De Vos; Isabelle Colle
Journal:  Int J Exp Pathol       Date:  2008-08       Impact factor: 1.925

9.  Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure.

Authors:  Shuangxi Wang; Jian Xu; Ping Song; Yong Wu; Junhua Zhang; Hyoung Chul Choi; Ming-Hui Zou
Journal:  Hypertension       Date:  2008-07-21       Impact factor: 10.190

10.  Vascular stasis, intestinal hemorrhage, and heightened vascular permeability complicate acute portal hypertension in cd39-null mice.

Authors:  Xiaofeng Sun; Andrés Cárdenas; Yan Wu; Keichi Enjyoji; Simon C Robson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-11       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.